Shares of health insurance provider Elevance Health (NYSE:EVH)
jumped 3% in the morning session after Wolfe Research upgraded the stock's rating to Outperform from Peerperform and set a price target of $425.
When Wall Street turns bearish on a stock, it’s worth paying attention.
These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
As the curtain closes on 2025, the investment community is witnessing a significant shift in sentiment regarding the managed care sector. Cigna Group (NYSE: CI) has become the centerpiece of this narrative, receiving a wave of analyst upgrades to ‘Buy’ in the final weeks of December. Market experts are increasingly
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Elevance Health (NYSE:ELV) and its peers.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Businesses with strong free cash flow tend to be more adaptable and resilient.
Some of these companies shine bright by using their cash wisely to strengthen their market positions.
